Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31506752 | 0.95 | GLP1R (0.44) | GLP1RSCTR | |
| SCHEMBL29684071 | 0.90 | OPRD1 (0.38) | GLP1RSCTR | |
| SCHEMBL29547706 | 0.89 | GLP1R (0.37) | GLP1RSCTR | |
| SCHEMBL676444 | 0.88 | GLP1R (0.47) | GLP1RSCTR | |
| SCHEMBL30124627 | 0.87 | GLP1R (0.40) | GLP1RSCTR | |
| SCHEMBL29375282 | 0.87 | GLP1R (0.56) | GLP1RSCTR | |
| SCHEMBL29837202 | 0.85 | GLP1R (0.36) | GLP1RSCTR | |
| SCHEMBL2465171 | 0.83 | GLP1R (0.51) | GLP1RSCTR | |
| SCHEMBL30091171 | 0.83 | GLP1R (0.58) | GLP1RSCTR | |
| SCHEMBL29538426 | 0.82 | OPRD1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240254186-A1 | GLP-1 Receptor Agonists Having Improved Pharmacological and Drug Delivery Properties | DARBIX LLC | 2024-08-01 | — | — | US | disclosed |
| WO-2023279323-A1 | METHOD FOR SYNTHESIZING GLP-1 ANALOG | 深圳翰宇药业股份有限公司 | 2023-01-12 | — | — | WO | disclosed |
| WO-2023279324-A1 | METHOD FOR SYNTHESIZING GLP-1 ANALOG | 深圳翰宇药业股份有限公司 | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254186-A1 | GLP-1 Receptor Agonists Having Improved Pharmacological and Drug Delivery Properties | GLP1R, GIPR, IAPP | GLP1R 1/4885SCTR 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.